N-(4-piperidinylmethyl)acetamide hydrobromide, 95.0%, 5g

2-(3',3'-Dimethyl-6-nitrospiro[chromene-2,2'-indolin]-1'-yl)ethanol, 93.0%, 25g

3'-fluoro-2-(3-pyrrolinomethyl) benzophenone, 97.0%, 1g

Pyrimidine-5-carbothioamide, 95.0%, 500mg

Stand plate with rods, Side insertion opening, 150 mm, 300 mm, 1 Piece

(3-Bromophenyl)diphenylphosphine oxide, 97%, 25g

1,3,5-Trimethyl-1H-pyrazole-4-carbaldehyde, 98.0%, 25g

4,4'-Diphenyl-2,2'-bipyridine, 97%, 5g

3,5-dibromo-1-[(3-bromophenyl)methyl]-1H-1,2,4-triazole, 95.0%, 1g

6-BROMO-1H-PYRROLO[3,2-B]PYRIDINE-2-CARBOXYLIC ACID, 95.0%, 250mg

GC capillary column ROTI®Cap-5 MS Ultra, 30 m, 0.25 mm, 1.00 µm, 1 Piece(s)

2-Methyl-2H-indazole, 95.0%, 250mg

3-((2S,5S)-5-Methyl-3,6-dioxopiperazin-2-yl)propanoic acid, 95.0%, 250mg